218 related articles for article (PubMed ID: 28121932)
1. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus.
Feng JF; Chen S; Yang X
Medicine (Baltimore); 2017 Jan; 96(4):e5886. PubMed ID: 28121932
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
[TBL] [Abstract][Full Text] [Related]
4. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma.
Wang L; Wang C; Wang J; Huang X; Cheng Y
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2077-2086. PubMed ID: 28601935
[TBL] [Abstract][Full Text] [Related]
5. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.
Chen S; Yang X; Feng JF
Oncotarget; 2016 Sep; 7(38):62123-62132. PubMed ID: 27557504
[TBL] [Abstract][Full Text] [Related]
6. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis.
Geng Y; Shao Y; Zhu D; Zheng X; Zhou Q; Zhou W; Ni X; Wu C; Jiang J
Sci Rep; 2016 Dec; 6():39482. PubMed ID: 28000729
[TBL] [Abstract][Full Text] [Related]
7. Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma.
Fu M; Li Z; Ma J; Shen F; Zhang X
Scand J Gastroenterol; 2024 Jun; 59(6):722-729. PubMed ID: 38362884
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
9. The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy.
Obata Y; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
Surg Today; 2023 Aug; 53(8):964-972. PubMed ID: 36797438
[TBL] [Abstract][Full Text] [Related]
10. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
Xie X; Luo KJ; Hu Y; Wang JY; Chen J
Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
[TBL] [Abstract][Full Text] [Related]
12. Systemic Immune-inflammation Index Predicts Survival of Patients After Curative Resection for Non-small Cell Lung Cancer.
Tomita M; Ayabe T; Maeda R; Nakamura K
In Vivo; 2018; 32(3):663-667. PubMed ID: 29695576
[TBL] [Abstract][Full Text] [Related]
13. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
14. A Nomogram to Predict Prognostic Value of Red Cell Distribution Width in Patients with Esophageal Cancer.
Chen GP; Huang Y; Yang X; Feng JF
Mediators Inflamm; 2015; 2015():854670. PubMed ID: 26578822
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.
Feng J; Wang L; Wang L; Yang X; Lou G
BMC Cancer; 2022 Mar; 22(1):284. PubMed ID: 35300627
[TBL] [Abstract][Full Text] [Related]
16. Predicting prognosis in resected esophageal squamous cell carcinoma using a clinical nomogram and recursive partitioning analysis.
Zheng Y; Fu S; He T; Yan Q; Di W; Wang J
Eur J Surg Oncol; 2018 Aug; 44(8):1199-1204. PubMed ID: 29784506
[TBL] [Abstract][Full Text] [Related]
17. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
[No Abstract] [Full Text] [Related]
18. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
19. Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Feng JF; Liu JS; Huang Y
Medicine (Baltimore); 2014 Dec; 93(27):e257. PubMed ID: 25501097
[TBL] [Abstract][Full Text] [Related]
20. The preoperative hemoglobin, albumin, lymphocyte and platelet (HALP) score is a useful predictor in patients with resectable esophageal squamous cell carcinoma.
Feng JF; Wang L; Yang X
Bosn J Basic Med Sci; 2021 Dec; 21(6):773-781. PubMed ID: 33974528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]